الصفحة الرئيسية>>Signaling Pathways>> Others>>Polybrene

Polybrene

رقم الكتالوجGC19206

بوليبرين (Polybrene) هو بوليمر موجب الشحنة يستخدم عادة لتعزيز كفاءة نقل الجينات المتوسطة بواسطة فيروسات التصارع.

Products are for research use only. Not for human use. We do not sell to patients.

Polybrene التركيب الكيميائي

Cas No.: 28728-55-4

الحجم السعر المخزون الكميّة
(10mg/ml) 1mL
16٫00
متوفر
(10mg/ml) 5mL
56٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Product has been cited by 3 publications

Description Protocol Chemical Properties Product Documents Related Video

Polybrene, a quaternary ammonium salt, was firstly introduced into clinical practice as a heparin neutralizer[1]. Besides, polybrene at lower doses was popularly used to promote the efficiency of virus-mediated gene transfer both in vivo and in vitro[2-5]. Polybrene promote the binding of viruses on the cell surface by neutralizing the electrostatic repulsion between the opposing bilayers[6-7].

Polybrene(0-32 µg/mL;24h) displays concentration-dependent effects. Starting at concentrations as low as 4 µg/mL, distinct neuritic beads emerge, whereas a concentration of 8 µg/mL induces neuritic fragmentation[8]. Polyethylene(8µg/mL) significantly reduced the proliferation rate of Mesenchymal stem cells (MSCs) [9]. Polybrene markedly enhances the efficiency of lipofection and also compensates the serum-mediated inhibition of lipofection in a variety of cell lines[10].

Polybrene(4 µg/µL;ICV) injection resulted in mice exhibiting motor dysfunction on the third day.Polybrene induces neural death and gliosis in mice[8].

References:
[1]. Weiss.W. A, Gilman, J. S, et,al. Heparin neutralization with polybrene administered intravenously. J. Am. Med. Assoc. 166, 603-607 (1958).
[2]. Davis, H. E., Morgan, J. R. et,al. Polybrene increases retrovirus gene transfer efficiency by enhancing receptor-independent virus adsorption on target cell membranes. Biophys. Chem. 97, 159-172 (2002).
[3]. Bellodi-Privato, M. et al. AAV gene transfer to the retina does not protect retrovirally transduced hepatocytes from the immune response. J. Mol. Med (Berl.). 82, 403-410 (2004).
[4]. Lauwers, E. et al. Neuropathology and neurodegeneration in rodent brain induced by lentiviral vector-mediated overexpression of alpha-synuclein. Brain Pathol. 13, 364-372 (2003).
[5]. Ferry, N., Duplessis, O., et,al. Retroviral-mediated gene transfer into hepatocytes in vivo. Proc. Natl Acad. Sci. USA 88, 8377-8381 (1991).
[6]. Sinn, P. L., Sauter, S. L. et,al. Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors--design, biosafety, and production. Gene Ther. 12, 1089-1098 (2005).
[7]. Kafri, T. Lentivirus vectors: difficulties and hopes before clinical trials. Curr. Opin. Mol. Ther. 3, 316-326 (2001).
[8]. Bao F, Shi H, et,al. Polybrene induces neural degeneration by bidirectional Ca2+ influx-dependent mitochondrial and ER-mitochondrial dynamics. Cell Death Dis. 2018 Sep 20;9(10):966. doi: 10.1038/s41419-018-1009-8. PMID: 30237514; PMCID: PMC6148003.
[9].Lin P, Correa D, et,al. Polybrene inhibits human mesenchymal stem cell proliferation during lentiviral transduction. PLoS One. 2011;6(8):e23891. doi: 10.1371/journal.pone.0023891. Epub 2011 Aug 26. PMID: 21887340; PMCID: PMC3162604.
[10].Abe A, Miyanohara A, Friedmann T. Polybrene increases the efficiency of gene transfer by lipofection. Gene Ther. 1998 May;5(5):708-11. doi: 10.1038/sj.gt.3300652. PMID: 9797877.

مراجعات

Review for Polybrene

Average Rating: 5 ★★★★★ (Based on Reviews and 25 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Polybrene

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.